Latest stories on COLL
Leerink bullish on Collegium Pharmaceutical, initiates with an Outperform
The Fly61 · neutralanalyst
Collegium Pharmaceutical initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
Collegium Pharmaceutical assumed with a Buy at Truist
The Fly63 · neutralanalyst
Collegium to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Collegium to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays
The Fly38 · neutralanalyst
Why is Collegium Pharmaceutical stock climbing today?
Investing.com Markets50 · neutralgeneral
Collegium Pharmaceutical stock jumps on $50M share buyback
Investing.com Markets71 · bullishgeneral
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Collegium Pharmaceutical Launches $50 Million Accelerated Share Buyback
TipRanks71 · bullishgeneral
Collegium gains on $50M accelerated share buyback program
Seeking Alpha71 · bullishgeneral
COLLEGIUM PHARMACEUTICAL, INC (COLL) files 8-K
SEC 8-K50 · neutralgeneral
Collegium Announces $50 Million Accelerated Share Repurchase Program
Business Insider71 · bullishgeneral
Collegium Announces $50 Million Accelerated Share Repurchase Program
GlobeNewswire71 · bullishgeneral
Northlight Wine Collective Acquires Meyer Family Vineyards and Mayhem Wines
Business Insider63 · neutralm&a
Collegium Pharmaceutical, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Collegium Pharmaceutical, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
Collegium targets $65M-$75M in 2026 Azstarys revenue while holding Jornay PM at $190M-$200M
Seeking Alpha63 · neutralearnings
Collegium Pharmaceutical, Inc. (COLL) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Why is Collegium Pharmaceutical stock tumbling today?
Investing.com Markets34 · bearishgeneral
Collegium Pharmaceutical Q2 Earnings Call Highlights
Yahoo Top56 · neutralearnings
COLLEGIUM PHARMACEUTICAL, INC (COLL) files 8-K
SEC 8-K50 · neutralgeneral
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
Business Insider63 · neutralearnings
Collegium Pharmaceutical: Pain Cash Flows Are Funding An ADHD Re-Rating
Seeking Alpha67 · bullishproduct/pr
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
Business Insider50 · neutralgeneral